C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
OBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, tre...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4342263?pdf=render |
id |
doaj-7846c2a4c66a479997e5e3fb2bed1f56 |
---|---|
record_format |
Article |
spelling |
doaj-7846c2a4c66a479997e5e3fb2bed1f562020-11-24T21:49:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01102e011742410.1371/journal.pone.0117424C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.Mark W TenfordeNikhil GupteDavid W DowdyDavid M AsmuthAshwin BalagopalRichard B PollardPatcharaphan SugandhavesaJavier R LamaSandy PillaySandra W CardosoJyoti PawarBreno SantosCynthia RiviereNoluthando MwelaseCecilia KanyamaJohnstone KumwendaJames G HakimNagalingeswaran KumarasamyRobert BollingerRichard D SembaThomas B CampbellAmita GuptaACTG PEARLS and NWCS 319 Study GroupOBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naïve adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm). METHODS:We measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-γ), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-α), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus undetectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis. RESULTS:Seventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB. CONCLUSION:Incident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators.http://europepmc.org/articles/PMC4342263?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mark W Tenforde Nikhil Gupte David W Dowdy David M Asmuth Ashwin Balagopal Richard B Pollard Patcharaphan Sugandhavesa Javier R Lama Sandy Pillay Sandra W Cardoso Jyoti Pawar Breno Santos Cynthia Riviere Noluthando Mwelase Cecilia Kanyama Johnstone Kumwenda James G Hakim Nagalingeswaran Kumarasamy Robert Bollinger Richard D Semba Thomas B Campbell Amita Gupta ACTG PEARLS and NWCS 319 Study Group |
spellingShingle |
Mark W Tenforde Nikhil Gupte David W Dowdy David M Asmuth Ashwin Balagopal Richard B Pollard Patcharaphan Sugandhavesa Javier R Lama Sandy Pillay Sandra W Cardoso Jyoti Pawar Breno Santos Cynthia Riviere Noluthando Mwelase Cecilia Kanyama Johnstone Kumwenda James G Hakim Nagalingeswaran Kumarasamy Robert Bollinger Richard D Semba Thomas B Campbell Amita Gupta ACTG PEARLS and NWCS 319 Study Group C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS ONE |
author_facet |
Mark W Tenforde Nikhil Gupte David W Dowdy David M Asmuth Ashwin Balagopal Richard B Pollard Patcharaphan Sugandhavesa Javier R Lama Sandy Pillay Sandra W Cardoso Jyoti Pawar Breno Santos Cynthia Riviere Noluthando Mwelase Cecilia Kanyama Johnstone Kumwenda James G Hakim Nagalingeswaran Kumarasamy Robert Bollinger Richard D Semba Thomas B Campbell Amita Gupta ACTG PEARLS and NWCS 319 Study Group |
author_sort |
Mark W Tenforde |
title |
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
title_short |
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
title_full |
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
title_fullStr |
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
title_full_unstemmed |
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
title_sort |
c-reactive protein (crp), interferon gamma-inducible protein 10 (ip-10), and lipopolysaccharide (lps) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
OBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naïve adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm). METHODS:We measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-γ), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-α), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus undetectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis. RESULTS:Seventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB. CONCLUSION:Incident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators. |
url |
http://europepmc.org/articles/PMC4342263?pdf=render |
work_keys_str_mv |
AT markwtenforde creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT nikhilgupte creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT davidwdowdy creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT davidmasmuth creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT ashwinbalagopal creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT richardbpollard creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT patcharaphansugandhavesa creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT javierrlama creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT sandypillay creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT sandrawcardoso creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT jyotipawar creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT brenosantos creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT cynthiariviere creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT noluthandomwelase creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT ceciliakanyama creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT johnstonekumwenda creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT jamesghakim creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT nagalingeswarankumarasamy creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT robertbollinger creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT richarddsemba creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT thomasbcampbell creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT amitagupta creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings AT actgpearlsandnwcs319studygroup creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings |
_version_ |
1725887822234124288 |